Cliff Asness's ARCT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 161,278 shares of Arcturus Therapeutics Holdings Inc. (ARCT) worth $1.25 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ARCT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 121,526 shares. Largest reduction occurred in Q1 2024, reducing 85,648 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Arcturus Therapeutics Holdings (ARCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arcturus Therapeutics Holdings (ARCT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +117,875 | Add 271.58% | 161,278 | $7.72 |
| Q4 2025 | +43,403 | New Buy | 43,403 | $6.13 |
| Q3 2025 | -11,218 | Sold Out | 0 | $0.00 |
| Q2 2025 | -849 | Reduce 7.04% | 11,218 | $13.01 |
| Q1 2025 | +12,067 | New Buy | 12,067 | $10.59 |
| Q4 2024 | -12,078 | Sold Out | 0 | $0.00 |
| Q3 2024 | +378 | Add 3.23% | 12,078 | $23.21 |
| Q2 2024 | -62,525 | Reduce 84.24% | 11,700 | $24.35 |
| Q1 2024 | -85,648 | Reduce 53.57% | 74,225 | $33.77 |
| Q4 2023 | -12,329 | Reduce 7.16% | 159,873 | $31.53 |
| Q3 2023 | +121,526 | Add 239.81% | 172,202 | $25.55 |
| Q2 2023 | +50,676 | New Buy | 50,676 | $28.68 |
| Q1 2021 | -11,914 | Sold Out | 0 | $0.00 |
| Q4 2020 | -4,842 | Reduce 28.90% | 11,914 | $43.39 |
| Q3 2020 | +16,756 | New Buy | 16,756 | $42.91 |
Cliff Asness's Arcturus Therapeutics Holdings Investment FAQs
Cliff Asness first purchased Arcturus Therapeutics Holdings Inc. (ARCT) in Q3 2020, acquiring 16,756 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Arcturus Therapeutics Holdings Inc. (ARCT) for 15 quarters since Q3 2020.
Cliff Asness's largest addition to Arcturus Therapeutics Holdings Inc. (ARCT) was in Q3 2023, adding 172,202 shares worth $4.4 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 161,278 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $1.25 M.
As of the Q1 2026 filing, Arcturus Therapeutics Holdings Inc. (ARCT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Arcturus Therapeutics Holdings Inc. (ARCT) was 172,202 shares, as reported at the end of Q3 2023.